Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction

Diabetologia

Volumn 41, Issue 10, 1998, Pages 1220-1226

  Pieper, G M ^a,b   Dembny, K ^a   Siebeneich, W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Endothelium; Nitric oxide

Indexed keywords

ACETYLCHOLINE; GLUCOSE; GLYCERYL TRINITRATE; GLYCOSYLATED HEMOGLOBIN; INSULIN; NITRATE; NITRIC OXIDE; NITRITE; NOX 101; SCAVENGER; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

ANIMALS; AORTA; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HEMOGLOBIN A, GLYCOSYLATED; INSULIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NOREPINEPHRINE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; THIOCARBAMATES;

EID: 0031782803     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051055     Document Type: Article

References (67)

1. Pieper GM, Gross GJ (1991) Endothelial dysfunction in diabetes. In: Rubanyi GM (ed) Cardiovascular Significance of Endothelium-Derived Vasoactive Factors, Futura Publishing Co., Mount Kisco, N. Y., pp 223-249
2. Cohen RA (1993) Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 [suppl V]:V67-V76
3. Kamata K, Miyata N, Abiru T, Kasuya Y (1992) Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci 50: 1379-1387
4. Poston L, Taylor PD (1995) Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sei (Colch) 88: 245-255
5. Sobrevia L, Mann GE (1997) Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycemia. Exp Physiol 82: 423-52
6. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516
7. McNally PG, Watt PAC, Rimmer T, Burdern AC, Hearnshaw JR, Thurston H (1994) Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with endothelium-dependent diabetes mellitus. Clin Sei 87: 313-336
8. McVeigh GE, Brennan GM, Johnston GD et al. (1992) Impaired endothelium-dependent and independent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771-776
9. 2. Am J Physiol 57 (Heart Circ Physiol 26): H1327-H1333
10. Mayhan WG (1989) Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol 256 (Heart Circ Physiol 25): H621-H625
11. Pelligrino DA, Koenig HM, Wang Q, Albrecht RF (1994) Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. NeuroReport 5: 417-420
12. Pieper GM, Peltier BA (1995) Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol 25: 397-403
13. Pieper GM, Jordan M, Adams MB, Roza AM (1995) Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes. Diabetes 44: 1106-1113
14. Pieper GM (1997) Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopeterin. J Cardiovasc Pharmacol 29: 8-15
15. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87: 432-438
16. Langenstroer P, Pieper GM (1992) Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 263 (Heart Circ Physiol 32): H257-H265
17. Pieper GM, Mei DA, Langenstroer P, O'Rourke ST (1992) Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol 263 (Heart Circ Physiol 32): H676-H680
18. Diederich D, Skopec J, Diederich A, Dai FX (1994) Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266 (Heart Circ Physiol 35):H1153-H1161
19. Pieper GM, Moore-Hilton G, Roza AM (1996) Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sei 58:PL147-PL152
20. Tesfamariam B, Cohen RA (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263 (Heart Circ Physiol 32):H321-H326
21. Rösen P, Ballhausen T, Stockklauser K (1996) Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res Clin Pract 31 [suppl 1]:S143-S155
22. Tilton RG, Chang K, Hasan KS et al. (1993) Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42: 221-232
23. Corbett JA, Tilton RG, Chang K et al. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556
24. Lai C-S, Komarov AM (1995) Dithiocarbamate spin traps for in vivo detection of nitric oxide production in mice. In: OhyaNishiguchi H, Packer L (ed) Bioradicals Detected by ESR Spectroscopy Birkhäuser-Verlag, Basel, pp 163-171
25. 2+ with diethyldithiocarbamate or N-methyl-D-glucamine dithiocarbamate as traps of nitric oxide in animal tissues: comparative investigations. Biochim Biophys Acta 1336: 225-234
26. Pieper GM, Gross GJ (1988) Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 255 (Heart Circ Physiol 24):H825-H833
27. Pieper GM, Langenstroer P, Siebeneich W (1997) Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 34: 45-156
28. Cameron NE, Cotter MA (1992) Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35: 1011-1019
29. Tesfamariam B, Palacino JJ, Weisbrod RM, Cohen RA (1993) Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 21: 205-211
30. Keegan A, Walbank H, Cotter MA, Cameron NE (1995) Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 38: 1475-1478
31. Rösen P, Ballhousen T, Bloch W, Addicks K (1995) Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38: 1157-1168
32. Cameron NE, Cotter MA, Dines KC, Maxfield EK (1993) Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozolocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36: 516-522
33. Pieper GM (1998) Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060
34. Bhardwaj R, Moore PK (1988) Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol 40: 739-742
35. Heygate KM, Davies J, Holmes M, James RFL, Thurston H (1996) The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat. Br J Pharmacol 119: 495-504
36. Pieper GM, Siebeneich W (1998) Early augmentation of nitric oxide-mediated endothelium-dependent relaxation in streptozotocin-diabetic rat aorta. Naunyn-Schmiedeberg's Archiv Pharmacol (358 [Suppl I]: R304) (abstract)
37. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM (1993) Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of NO. Am J Physiol 265 (Renal Fluid Electrolyte Physiol 34): F886-F895
38. Reyes AA, Karl IE, Kissane J, Klahr S (1993) L-Arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 4: 1039-1045
39. Bank N, Aynedjian HS (1993) Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43: 1306-1312
40. Komers R, Allen TJ, Cooper ME (1994) Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43: 1190-1197
41. Soulis T, Cooper ME, Sastra S et al. (1997) Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Diabetologia 40: 1141-1151
42. Archibald V, Cotter MA, Keegan A, Cameron NE (1996) Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments. Naunyn-Schmiedeberg's Arch Pharmacol 353: 584-591
43. Dai FX, Skopec J, Diederich A, Diederich D (1995) Amino-guanidine ameliorates diabetic endothelial dysfunction: potential role of inhibition of inducible nitric oxide synthase. FASEB J 9:A599 (abstract)
44. Hill MA, Ege EA (1994) Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effects of aminoguanidine treatment. Diabetes 43: 450-456
45. Kolb H, Kiesel U, Krönke KD. Kolb-Bachofen V (1991) Suppression of low dose streptozotocin induced diabetes in mice by administration of nitric oxide synthase inhibitor. Life Sci 49: 213-217
46. Lukic ML, Stosic-Grujicic S, Ostojic N, Chan WL, Liew FY (1991) Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem Biophys Res Commun 178: 913-920
47. Catanzaro OL, Marina-Prendes MG, Hope SI, Zuccollo A, Dominguez A (1994) Streptozotocin-induced hyperglycemia is decreased by nitric oxide inhibition. Braz J Med Res 27: 2043-2047
48. Laszlo F, Evans SM, Whittle BJR (1995) Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol 272: 169-175
49. Hui JY, Taylor SL (1985) Inhibition of in vivo histamine metabolism in rats by foodborne and pharmacologic inhibitors of diamine oxidase, histamine N-methyltransferase and monoamine oxidase. Toxicol Appl Pharmacol 81: 241-249
50. Edelstein D, Brownlee M (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29
51. Philis-Tsimikas A, Parthasarathy S, Picard S, Palinski W, Witztum JL (1995) Aminoguanidine has both pro-oxidant and anti-oxidant activity toward LDL. Arterioscler Thromb Vasc Biol 15: 367-376
52. Hunt JV, McKay AG, Skamarauskas JT (1995) The pro-oxidant activity of aminoguanidine and protein glycation. Biochem Soc Trans 23: 250S
53. Lopez-Belmonte J, Whittle BJR (1995) Aminoguanidine-provoked leucocyte adherence to rat mesenteric venules: role of constitutive nitric oxide synthase inhibition. Brit J Pharmacol 116: 2710-2714
54. Zahner D, Malaisse WJ (1992) Effects of advanced glycation products and aminoguanidine upon insulin release. Diabetes Nutr Metab 5: 43-46
55. Tasaka Y, Nakaya F, Matsumoto H, Omori Y (1994) Effects of aminoguanidine on insulin release from pancreatic islets. Endocrine J 41: 309-313
56. Myers PR, Wright TF, Tanner MA, Adams HR (1992) EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin. Am J Physiol 262 (Heart Circ Physiol 31):H710-H718
57. Bult H, DeMeyer GRY, Jordaens FH, Herman AG (1991) Chronic exposure to exogenous nitric oxide may suppress its endogenous release and efficacy. J Cardiovasc Pharmacol 17 [suppl 3]:S79-S82
58. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ (1993) Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73: 808-812
59. Cooper M, Dembny K, Lindholm P, Lai C-S, Moore G, Johnson C, Adams M, Pieper G, Roza A (1997) Effect of nitric oxide scavenging and inhibition of NF-κB expression on cardiac allograft survival. Surg Forum 47: 500-503
60. Hiramoto K, Tomiyama S, Kikugawa K (1997) Appearance of electron spin resonance signals in the interaction of dithiocarbamate-Fe (II) with nitrogen dioxide and nitrite. Free Radical Biol Med 27: 505-509
61. Beckman JS, Beckman TW, Chen J, Marshall PA, Breeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624
62. Ohkuwa T, Sato Y, Naoi M (1995) Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 56: 1789-1798
63. Pieper GM, Siebeneich W, Roza AM, Jordan M, Adams MB (1996) Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 28: 741-745
64. Pieper GM, Siebeneich W (1997) Diabetes-induced dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol 30: 734-738
65. Paschenko SV, Khramtsov VV Skatchkov MR Plyusnin VF, Bassenge E (1996) EPR and laser flash photolysis studies of the reaction of nitric oxide with water soluble NO trap Fe (II)-proline-dithiocarbamate complex. Biochem Biophys Res Commun 225: 577-584
66. Mankhetkorn S, Abedinzadeh Z, Houee-Levin C (1994) Antioxidant action of sodium diethyldithiocarbamate reaction with hydrogen peroxide and superoxide radical. Free Radical Biol Med 17: 517-527
67. Fujii S, Ysohimura T, Kamada H (1996) Nitric oxide trapping efficiencies of water-soluble iron (III) complexes with dithiocarbamate derivatives. Chemistry Lett: 785-786